메뉴 건너뛰기




Volumn 79, Issue 928, 2003, Pages

Severe relapsing sulphonylurea-induced hypoglycaemia: A diagnostic and therapeutic challenge

Author keywords

[No Author keywords available]

Indexed keywords

GLICLAZIDE; GLUCOSE; INSULIN; SULFONYLUREA;

EID: 0345549533     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.928.120     Document Type: Article
Times cited : (5)

References (13)
  • 1
    • 0344207463 scopus 로고    scopus 로고
    • Safety issues in drug therapy of the diabetic patient
    • Krentz AJ, ed. Auckland: Adis Books
    • Gilbert R, Cooper M, Krum H. Safety issues in drug therapy of the diabetic patient. In: Krentz AJ, ed. Drug treatment of type 2 diabetes. Auckland: Adis Books, 2000: 45-60.
    • (2000) Drug Treatment of Type 2 Diabetes , pp. 45-60
    • Gilbert, R.1    Cooper, M.2    Krum, H.3
  • 2
    • 0033157113 scopus 로고    scopus 로고
    • Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: A review
    • Burge MR, Sood V, Sobhy TA, et al. Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review. Diabetes Obesity & Metabolism 1999;1:199-206.
    • (1999) Diabetes Obesity & Metabolism , vol.1 , pp. 199-206
    • Burge, M.R.1    Sood, V.2    Sobhy, T.A.3
  • 3
    • 0004223602 scopus 로고    scopus 로고
    • London: British Medical Association and Royal Pharmaceutical Society of Great Britain, September
    • Kendall MJ, ed. British national formulary. 44th Ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, September 2002.
    • (2002) British National Formulary. 44th Ed.
    • Kendall, M.J.1
  • 4
    • 0023350882 scopus 로고
    • The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs
    • Femer RE, Chaplin S. The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs. Clin Pharmacokinet 1987;12:379-401.
    • (1987) Clin Pharmacokinet , vol.12 , pp. 379-401
    • Femer, R.E.1    Chaplin, S.2
  • 5
    • 0022972005 scopus 로고
    • Dangerous misuse of sulphonylureas
    • Ludman P, Mason P, Joplin GF. Dangerous misuse of sulphonylureas. BMJ 1986;293:1287-8.
    • (1986) BMJ , vol.293 , pp. 1287-1288
    • Ludman, P.1    Mason, P.2    Joplin, G.F.3
  • 6
    • 0017649629 scopus 로고
    • Chlorpropamide-induced hypoglycemia: Successful treatment with diazoxide
    • Johnson SF, Schade DS, Peake GT. Chlorpropamide-induced hypoglycemia: successful treatment with diazoxide. Am J Med 1977;63:799-804.
    • (1977) Am J Med , vol.63 , pp. 799-804
    • Johnson, S.F.1    Schade, D.S.2    Peake, G.T.3
  • 7
    • 0025990636 scopus 로고
    • Clinical spectrum of sulfonylurea overdose and experience with diozoxide therapy
    • Palatnick W, Meatherall RC, Tenenbein M. Clinical spectrum of sulfonylurea overdose and experience with diozoxide therapy. Arch Intern Med 1991;151:1859-62.
    • (1991) Arch Intern Med , vol.151 , pp. 1859-1862
    • Palatnick, W.1    Meatherall, R.C.2    Tenenbein, M.3
  • 8
    • 0027457178 scopus 로고
    • Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses
    • Boyle PJ, Justice K, Krentz AJ, et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 1993;76:752-6.
    • (1993) J Clin Endocrinol Metab , vol.76 , pp. 752-756
    • Boyle, P.J.1    Justice, K.2    Krentz, A.J.3
  • 9
    • 0027470453 scopus 로고
    • Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide
    • Krentz AJ, Boyle PJ, Justice KM, et al. Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide. Diabetes Care 1993;16:184-6.
    • (1993) Diabetes Care , vol.16 , pp. 184-186
    • Krentz, A.J.1    Boyle, P.J.2    Justice, K.M.3
  • 11
    • 0030916462 scopus 로고    scopus 로고
    • Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes
    • Braatvedt GD. Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes. N Z Med J 1997;110:189-90.
    • (1997) N Z Med J , vol.110 , pp. 189-190
    • Braatvedt, G.D.1
  • 12
    • 0031021488 scopus 로고    scopus 로고
    • Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia
    • Graudins A, Linden CH, Ferm RP. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia. Am J Emerg Med 1997;15:95-6.
    • (1997) Am J Emerg Med , vol.15 , pp. 95-96
    • Graudins, A.1    Linden, C.H.2    Ferm, R.P.3
  • 13
    • 0033847854 scopus 로고    scopus 로고
    • Octreotide: An antidote for sulfonylurea-induced hypoglycemia
    • McLaughlin SA, Crandall CS, McKinney PE. Octreotide: an antidote for sulfonylurea-induced hypoglycemia. Ann Emerg Med 2000;36:133-8.
    • (2000) Ann Emerg Med , vol.36 , pp. 133-138
    • McLaughlin, S.A.1    Crandall, C.S.2    McKinney, P.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.